The U.S. Food and Drug Administration (FDA) granted emergency use authorization to several developers of molecular tests, including Hologic’s high-throughput Aptima SARS-CoV-2 assay, according to the FDA’s website.

Separately, the FDA also granted EUA to GeneMatrix for its NeoPlex COVID 19 Detection Kit and Applied DNA Sciences for its Linea COVID-19 Assay Kit. Both test kits are designed to run on real-time PCR instruments.